Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine versus oxycodone for postoperative pain after pelvic exenteration
ACTRN12625000901404Phase 4Not yet recruiting
- Sponsor
- University of Sydney
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Oxycodone + sublingual placebo with Buprenorphine + oral placebo (2 arms). Primary endpoint: Recruitment rate. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
buprenorphineoxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12625000901404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000901404.